Competitive Intelligence 2014: Hitachi/Aloka in the Global Diagnostic Imaging Sector

This strategic assessment of Hitachi/Aloka, one of the world's leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostic imaging market.

SECTION I: EXECUTIVE SUMMARY 

 - A 3-15 page synopsis of key sections.

SECTION II: BUSINESS ORGANIZATION 

 - History of the company’s diagnostic imaging business evolution, which is important to

   understanding the corporate culture, management mentality and strategies. 

 - Recent acquisitions, divestitures and major organizational changes. 

 - Current organizational structure. 

SECTION III: SENIOR MANAGEMENT 

 - Names, titles and background of key executives.

SECTION IV: FACILITIES AND EMPLOYEES 

 - Administrative, manufacturing and R&D facilities in the U.S. and abroad. 

 - Manufacturing practices. 

 - New plants under construction. 

 - The U.S. and international work force size and distribution.

SECTION V: TECHNOLOGICAL KNOW-HOW 

 - Internally developed and acquired diagnostic imaging and related technologies, including

   X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.

SECTION VI: PRODUCT PORTFOLIO

 - Placements and installed base of major systems in the U.S. and abroad, by modality.

 - Review of major product lines. 

 - Applications, advantages and weaknesses of leading products.

SECTION VII: MARKETING TACTICS 

 - Promotional tactics. 

 - Distribution approaches. 

 - Product service and support. 

 - Customer relations.

SECTION VIII: FINANCIAL ANALYSIS 

 - Estimated sales and operating profit by division, geographic region and product line. 

 - Five-year sales and operating profit performance.

SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS 

 - Estimated R&D budget. 

 - Research facilities and staff. 

 - New technologies, systems and applications in development.

SECTION X: COLLABORATIVE ARRANGEMENTS 

 - Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic. 

 - Terms of collaborative agreements and specific products involved.

SECTION XI: STRATEGIC DIRECTION 

 - Specific business, new product development and marketing strategies. 

 - Anticipated acquisitions, joint ventures and divestitures.

Contains 107 pages and 16 tables